Statistical Anti-Doping Report NADO Italia 2018 / Organizzazione Nazionale Antidoping (NADO Italia). - Roma : NADO Italia, 2019

NADA Annual Report 2018 / National Anti Doping Agency of Germany. - Bonn : Nationale Anti Doping Agentur Deutschland (NADA), 2019
NADA Material No. 76

Årsrapport 2018 Stiftelsen Antidoping Norge / Antidoping Norge (ADNO). - Oslo : ADNO, 2019

Anti-Doping Statistics of Turkisch Anti-Doping Commission for 2018 / Turkish Anti-Doping Commission (TADC). - Ankara : Türkiye Dopingle Mücadele Komisyonu (TDMK), 2019

Jaresbericht 2018 / Natonale Anti-Doping Agentur Austria (NADA Austria). - Wien : NADA Austria, 2019

Contents:

NADA AUSTRIA

• Leitbild, Vision und Mission
• Kommissionen
• Mitarbeiter
• Nationale und internationale Kooperationen

DOPINGKONTROLLSYSTEM

• Dopingkontrollprogramm 2018
• Athlete Biological Passport Program
• Dopingkontrollstatistik 2018
• Gesamtstatistik 2014-2018

MEDIZIN

• Medikamentenabfrage - MedApp
• Medizinische Ausnahmegenehmigungen

RECHT

• Regelwerke und Compliance
• Datenschutz, Überwachung der Einhaltung der Anti-Doping
• Bestimmungen
• Verstöße gegen die Anti-Doping Bestimmungen 2018

INFORMATION & PRÄVENTION

• 10 Jahre NADA Austria, Studie zur Wirksamkeit der
• Präventionsmaßnahmen
  Online
• Social Media
• Vorträge und Info-Tour
• Schulungsprogramme
• Kampagnen und Kooperatione

AUSBLICK NADA AUSTRIA
ANLAGEN

Annual Report 2017-2018 / Russian Anti-Doping Agency (RUSADA). - Moscow : Российское антидопинговое агентство (РУСАДА), 2018

Anti-doping Policy, Therapeutic Use Exemption and Medication Use in Athletes with Asthma : A Narrative Review and Critical Appraisal of Current Regulations / Hayden Allen, Susan H. Backhouse, James H. Hull, Oliver J. Price . - (Sports Medicine (2019) 18 March; p. 1-10).
- PMID: 30887312.
- DOI: 10.1007/s40279-019-01075-z

Abstract

Asthma is prevalent in athletes and when untreated can impact both respiratory health and sports performance. Pharmacological inhaler therapy currently forms the mainstay of treatment; however, for elite athletes competing under the constraints of the World Anti-Doping Code (Code), a number of established therapies are prohibited both in and/or out of competition and/or have a maximum permitted dose. The recent release of medical information detailing inhaler therapy in high-profile athletes has brought the legitimacy and utilisation of asthma medication in this setting into sharp focus. This narrative review critically appraises recent changes to anti-doping policy and the Code in the context of asthma management, evaluates the impact of asthma medication use on sports performance and employs a theory of behaviour to examine perceived determinants and barriers to athletes adhering to the anti-doping rules of sport when applied to asthma.

WADA at twenty : old problems and old thinking? / Ivan Waddington, Verner Møller

• International Journal of Sport Policy and Politics 11 (2019) 2, p. 219-231
• DOI: 10.1080/19406940.2019.1581645
• The World Anti-Doping Agency at 20: Progress and Challenges

ABSTRACT

The decision taken at Lausanne in 1999 to establish WADA represented a new start in anti-doping: a new organization under new leadership with new sources of funding, new headquarters and a new and wider anti-doping remit. The establishment of WADA also represented a potential new start in another way, for it offered an opportunity to develop fresh thinking and new approaches to anti-doping. To what extent has such fresh thinking been evident in WADA policy over the past twenty years? This question is examined via a focus on two key policy issues: WADA’s rationale for anti-doping policy and the reliance of WADA’s anti-doping policy on a strategy based on biological testing. What have been the implications of decisions in these areas for the outcomes of WADA policy, as measured by the number, and the type, of doping offences identified by WADA? It is argued that in many respects WADA’s policies represent a missed opportunity for, far from bringing new thinking or offering a new approach to anti-doping, WADA has for the most part simply reiterated and intensified policies which have a long history of failure and that those policies continue to be largely unsuccessful in controlling drug use in sport.